Sana Biotechnology SANA EBIT

EBIT at other companies

Bristol-Myers SquibbBMY

$4.09B+130%

Vertex PharmaceuticalsVRTX

$1.25B+8.3%

Gilead SciencesGILD

-$10.39B-520%

CRISPR TherapeuticsCRSP

-$130.25M+12.2%

Allogene TherapeuticsALLO

-$46.09M+29.3%

Ginkgo BioworksDNA

-$58.55M-0.7%

FAQ

What is Sana Biotechnology's EBIT?

Sana Biotechnology (SANA) reported EBIT of -$48.61M in Q1 2026.

How has Sana Biotechnology's EBIT changed year-over-year?

Sana Biotechnology's EBIT increased by 4.0% year-over-year, from -$50.63M to -$48.61M.

What is the long-term trend for Sana Biotechnology's EBIT?

Over 4 years (2021 to 2025), Sana Biotechnology's EBIT has grown at a -8.5% compound annual growth rate (CAGR), from -$356.91M to -$250.32M.

What does EBIT mean?

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.